Results 91 to 100 of about 1,543 (142)
Zhongguo shiyan zhenduanxue, 2011 目的研究临床分离大肠埃希菌的耐药机制及遗传多态性。方法用WHONET5.4分析菌株药敏情况。PCR检测大肠埃希菌I类整合酶基因、插入序列共同区（ISCR/orf513）和产超广谱β-内酰胺酶（ESBLs）基因;以肠杆菌科间的重复序列（ERIC）-PCR检测基因型,SPSS分析多态性。结果除亚胺培南、美洛培南、四环素和哌拉西林/他唑巴坦,产ESBLs菌的耐药率明显高于不产ESBLs菌 ...
王凤平 +5 more
doaj
Nosocomial Infections Caused by ESBL
Vaccines & Vaccination Open Access, 2019 openaire +1 more source
ESBL-producing organisms and cephalosporins.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1997 P, Derby, J, Berens
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Characterization of ESBL disseminating plasmids
Infectious Diseases, 2015Bacteria producing extended-spectrum β-lactamases (ESBLs) constitute a globally increasing problem that contributes to treatment complications and elevated death rates. The extremely successful dissemination by ESBL-producing Enterobacteriaceae during the latest decades is a result of the combination of mobilization, evolution and horizontal spread of ...
Alma, Brolund, Linus, Sandegren
openaire +2 more sources
Journal of Infection, 2007
This study was designed to compare cefepime exposures with microbiological outcomes in ESBL and non-ESBL infections and determine the pharmacodynamic profiles associated with successful outcome.Cefepime pharmacodynamic exposures of unbound drug [time above MIC (fT>MIC), minimal concentration over MIC (fC(min)/MIC), and area under the curve over MIC ...
Su Young, Lee +2 more
openaire +2 more sources
This study was designed to compare cefepime exposures with microbiological outcomes in ESBL and non-ESBL infections and determine the pharmacodynamic profiles associated with successful outcome.Cefepime pharmacodynamic exposures of unbound drug [time above MIC (fT>MIC), minimal concentration over MIC (fC(min)/MIC), and area under the curve over MIC ...
Su Young, Lee +2 more
openaire +2 more sources
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen
Journal of Clinical Microbiology, 1996Resistance to contemporary broad-spectrum beta-lactams, mediated by extended-spectrum beta-lactamase (ESBL) enzymes, is an increasing problem worldwide. The Etest (AB Biodisk, Solna, Sweden) ESBL screen uses stable gradient technology to evaluate the MIC of ceftazidime alone compared with the MIC of ceftazidime with clavulanic acid (2 micrograms/ml) to
M G, Cormican, S A, Marshall, R N, Jones
openaire +2 more sources
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention].
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2011To evaluate the change of extended spectrum beta-lactamase (ESBLs) Producing Klebsiella Pneumoniae (ESBLs-KPN) and Escherichia coli (ESBLs-ECO) causing nosocomial infection after antimicrobial intervention.We regularly monitored the data on the yearly consumption [defined as daily dose (DDD) per 1 000 patient-days] of frequently used antibiotics from ...
Yawen, Gao +4 more
openaire +1 more source
2017
Geachte mevrouw Abraham-Inpijn, u hebt aangeboden dat wij per mail vragen mogen stellen. Ik wil heel graag op uw aanbod terugkomen. Ik heb een patient in een verpleegkliniek. Hij komt min of meer regelmatig naar mijn praktijk voor onder andere gebitsreiniging.
openaire +1 more source
Geachte mevrouw Abraham-Inpijn, u hebt aangeboden dat wij per mail vragen mogen stellen. Ik wil heel graag op uw aanbod terugkomen. Ik heb een patient in een verpleegkliniek. Hij komt min of meer regelmatig naar mijn praktijk voor onder andere gebitsreiniging.
openaire +1 more source